Overview
Dyschondrosteosis-nephritis syndrome is an extremely rare condition that has been described in medical literature but is now classified as obsolete in disease databases, meaning it may have been reclassified, merged with another condition, or its original description may no longer be considered a distinct entity. The syndrome was originally described as a combination of dyschondrosteosis (a skeletal disorder affecting bone growth, particularly in the forearms and lower legs, leading to short stature and a characteristic wrist deformity called Madelung deformity) along with nephritis (inflammation of the kidneys). Patients with this condition were reported to have short stature with disproportionately short limbs, wrist abnormalities, and kidney problems that could affect how the kidneys filter blood and produce urine. Because this condition is now considered obsolete, it is possible that the skeletal and kidney features are now understood to belong to separate or overlapping conditions. Patients who were previously given this diagnosis should work with their medical team to determine whether a more current diagnosis applies. Treatment would have been directed at managing the individual symptoms, including orthopedic care for bone abnormalities and nephrology care for kidney disease.
Key symptoms:
Short statureDisproportionately short forearms and lower legsWrist deformity (Madelung deformity)Bowing of the forearm bonesKidney inflammation (nephritis)Blood or protein in the urineSwelling due to kidney problemsLimited wrist movementBone growth abnormalities
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Dyschondrosteosis-nephritis syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Dyschondrosteosis-nephritis syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Dyschondrosteosis-nephritis syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Dyschondrosteosis-nephritis syndrome.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Dyschondrosteosis-nephritis syndrome.
Start the conversation →Latest news about OBSOLETE: Dyschondrosteosis-nephritis syndrome
No recent news articles for OBSOLETE: Dyschondrosteosis-nephritis syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Is this diagnosis still considered valid, or should we pursue updated genetic testing to get a more current diagnosis?,How severe is the kidney involvement, and what is the long-term outlook for kidney function?,Would genetic testing for the SHOX gene or whole exome sequencing help clarify the diagnosis?,Are there surgical options for the wrist deformity, and when is the best time to consider them?,Should my child be evaluated for growth hormone therapy?,How often should kidney function be monitored, and what warning signs should I watch for at home?,Are there any clinical trials or research studies that might be relevant to this condition?
Common questions about OBSOLETE: Dyschondrosteosis-nephritis syndrome
What is OBSOLETE: Dyschondrosteosis-nephritis syndrome?
Dyschondrosteosis-nephritis syndrome is an extremely rare condition that has been described in medical literature but is now classified as obsolete in disease databases, meaning it may have been reclassified, merged with another condition, or its original description may no longer be considered a distinct entity. The syndrome was originally described as a combination of dyschondrosteosis (a skeletal disorder affecting bone growth, particularly in the forearms and lower legs, leading to short stature and a characteristic wrist deformity called Madelung deformity) along with nephritis (inflammat
At what age does OBSOLETE: Dyschondrosteosis-nephritis syndrome typically begin?
Typical onset of OBSOLETE: Dyschondrosteosis-nephritis syndrome is childhood. Age of onset can vary across affected individuals.